Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Effects of Immunoglobulins G From Systemic Sclerosis Patients in Normal Dermal Fibroblasts: A Multi-Omics Study.
Front Immunol. 2022 Jun 29;13:904631. doi: 10.3389/fimmu.2022.904631. eCollection 2022.
Front Immunol. 2022.
PMID: 35844491
Free PMC article.
Transcriptomic signatures of brain regional vulnerability to Parkinson's disease.
Keo A, Mahfouz A, Ingrassia AMT, Meneboo JP, Villenet C, Mutez E, Comptdaer T, Lelieveldt BPF, Figeac M, Chartier-Harlin MC, van de Berg WDJ, van Hilten JJ, Reinders MJT.
Keo A, et al. Among authors: meneboo jp.
Commun Biol. 2020 Mar 5;3(1):101. doi: 10.1038/s42003-020-0804-9.
Commun Biol. 2020.
PMID: 32139796
Free PMC article.
Item in Clipboard
MET variants with activating N-lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulation.
Guérin C, Vinchent A, Fernandes M, Damour I, Laratte A, Tellier R, Estevam GO, Meneboo JP, Villenet C, Descarpentries C, Fraser JS, Figeac M, Cortot AB, Rouleau E, Tulasne D.
Guérin C, et al. Among authors: meneboo jp.
bioRxiv [Preprint]. 2023 Nov 7:2023.11.03.565283. doi: 10.1101/2023.11.03.565283.
bioRxiv. 2023.
PMID: 37965202
Free PMC article.
Preprint.
Item in Clipboard
Transforming properties of MET receptor exon 14 skipping can be recapitulated by loss of the CBL ubiquitin ligase binding site.
Fernandes M, Paget S, Kherrouche Z, Truong MJ, Vinchent A, Meneboo JP, Sebda S, Werkmeister E, Descarpentries C, Figeac M, Cortot AB, Tulasne D.
Fernandes M, et al. Among authors: meneboo jp.
FEBS Lett. 2023 Sep;597(18):2301-2315. doi: 10.1002/1873-3468.14702. Epub 2023 Jul 28.
FEBS Lett. 2023.
PMID: 37468447
Item in Clipboard
MET exon 14 skipping mutation is a hepatocyte growth factor (HGF)-dependent oncogenic driver in vitro and in humanised HGF knock-in mice.
Fernandes M, Hoggard B, Jamme P, Paget S, Truong MJ, Grégoire V, Vinchent A, Descarpentries C, Morabito A, Stanislovas J, Farage E, Meneboo JP, Sebda S, Bouchekioua-Bouzaghou K, Nollet M, Humez S, Perera T, Fromme P, Grumolato L, Figeac M, Copin MC, Tulasne D, Cortot AB, Kermorgant S, Kherrouche Z.
Fernandes M, et al. Among authors: meneboo jp.
Mol Oncol. 2023 Nov;17(11):2257-2274. doi: 10.1002/1878-0261.13397. Epub 2023 Jul 14.
Mol Oncol. 2023.
PMID: 36799689
Free PMC article.
Item in Clipboard
Cite
Cite